Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals
- PMID: 36746545
- PMCID: PMC9906300
- DOI: 10.1136/bmjopen-2022-069244
Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals
Abstract
Objectives: We evaluated the accuracy of using routine health service data to identify hospital-acquired thrombosis (HAT) and major bleeding events (MBE) compared with a reference standard of case note review.
Design: A multicentre observational cohort study.
Setting: Four acute hospitals in the UK.
Participants: A consecutive unselective cohort of general medical and surgical patients requiring hospitalisation for a period of >24 hours during the calendar year 2021. We excluded paediatric, obstetric and critical care patients due to differential risk profiles.
Interventions: We compared preidentified sources of routinely collected information (using hospital coding data and local contractually mandated thrombosis datasets) to data extracted from case notes using a predesigned workflow methodology.
Primary and secondary outcome measures: We defined HAT as objectively confirmed venous thromboembolism occurring during hospital stay or within 90 days of discharge and MBE as per international consensus.
Results: We were able to source all necessary routinely collected outcome data for 87% of 2008 case episodes reviewed. The sensitivity of hospital coding data (International Classification of Diseases 10th Revision, ICD-10) for the diagnosis of HAT and MBE was 62% (95% CI, 54 to 69) and 38% (95% CI, 27 to 50), respectively. Sensitivity improved to 81% (95% CI, 75 to 87) when using local thrombosis data sets.
Conclusions: Using routinely collected data appeared to miss a substantial proportion of outcome events, when compared with case note review. Our study suggests that currently available routine data collection methods in the UK are inadequate to support efficient study designs in venous thromboembolism research.
Trial registration number: NIHR127454.
Keywords: anticoagulation; risk management; thromboembolism.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: During the completion of this study, SG, DH, CR, BJH, MBu and MB received funding from the National Institute of Health Research (NIHR) for academic work in this area, through competitive grant application and CR was appointed to an NIHR doctoral research fellow position. Following the completion of this study, CR has been subsequently employed by Pfizer limited. Pfizer did not fund nor support this study and was not involved in drafting or revising this manuscript.
Similar articles
-
Association of pharmacologic thromboprophylaxis with clinically relevant bleeding and hospital-acquired anemia in medical inpatients: the risk stratification for hospital-acquired venous thromboembolism in medical patients study.J Thromb Haemost. 2024 Mar;22(3):765-774. doi: 10.1016/j.jtha.2023.11.021. Epub 2023 Dec 9. J Thromb Haemost. 2024. PMID: 38072378
-
Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study.BMJ Open. 2020 Nov 3;10(11):e038102. doi: 10.1136/bmjopen-2020-038102. BMJ Open. 2020. PMID: 33148732 Free PMC article.
-
Can We Use Routinely Collected Healthcare Data for a Nationwide Trial on Venous Thromboembolism Prophylaxis Following Primary Joint Replacement? A Feasibility Study.J Arthroplasty. 2020 Aug;35(8):1983-1985. doi: 10.1016/j.arth.2020.03.033. Epub 2020 Mar 26. J Arthroplasty. 2020. PMID: 32340827
-
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.Cochrane Database Syst Rev. 2020 Oct 10;10(10):CD013399. doi: 10.1002/14651858.CD013399.pub2. Cochrane Database Syst Rev. 2020. PMID: 33038027 Free PMC article.
-
Treatment of distal deep vein thrombosis.Cochrane Database Syst Rev. 2020 Apr 9;4(4):CD013422. doi: 10.1002/14651858.CD013422.pub2. Cochrane Database Syst Rev. 2020. PMID: 32271939 Free PMC article.
Cited by
-
Comparing Claims Data to Stroke and Bleeding in the NCDR Left Atrial Appendage Occlusion Registry.JACC Adv. 2025 Jul 24;4(8):102019. doi: 10.1016/j.jacadv.2025.102019. Online ahead of print. JACC Adv. 2025. PMID: 40712270 Free PMC article.
-
The role of health policy in the prevention of venous thromboembolism in the UK National Health Service-Learning from the past, looking to the future.Future Healthc J. 2024 Feb 28;11(1):100016. doi: 10.1016/j.fhj.2024.100016. eCollection 2024 Mar. Future Healthc J. 2024. PMID: 38646038 Free PMC article.
-
Who dies from venous thromboembolism after hospitalisation for other reasons in England?: a national retrospective cohort study.BMJ Open. 2024 May 20;14(5):e082951. doi: 10.1136/bmjopen-2023-082951. BMJ Open. 2024. PMID: 38772580 Free PMC article.
-
Derivation and external validation of a portable method to identify patients with pulmonary embolism from radiology reports: The READ-PE algorithm.Thromb Res. 2024 Sep;241:109105. doi: 10.1016/j.thromres.2024.109105. Epub 2024 Jul 26. Thromb Res. 2024. PMID: 39116484
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical